This blog posting represents the views of the author, David Fosberry. Those opinions may change over time. They do not constitute an expert legal or financial opinion.

If you have comments on this blog posting, please email me .

The Opinion Blog is organised by threads, so each post is identified by a thread number ("Major" index) and a post number ("Minor" index). If you want to view the index of blogs, click here to download it as an Excel spreadsheet.

Click here to see the whole Opinion Blog.

To view, save, share or refer to a particular blog post, use the link in that post (below/right, where it says "Show only this post").

Round-up of Covid-19 news.

Posted on 17th March 2021

Show only this post
Show all posts in this thread (Covid-19).

Mutant Virus Variants

More and more variants of the coronavirus are being discovered, as reported here by the BBC, and here by the BBC.

Vaccines and Immunity

There is a steady stream of new vaccines becoming available:

Of course, these new jabs need to be approved before they become available for the general population, but governments have shown that they can fast track these approvals, so there should only be a small delay.

The French government is now saying that just one jab is needed for people previously infected with Covid-19, as reported here by the BBC.

Do vaccines prevent transmission?

The jury is definitely still out, on this point. Some research suggests that the vaccines do help prevent transmission, but some suggests not.

This report on Reason suggests that there is strong evidence that vaccination curtails (i.e. doesn't completely prevent) virus transmission.

This report on New Atlas also suggests mRNA vaccines (i.e. the Pfizer and Moderna vaccines) prevent onward transmission.

Do the vaccines work against the new variants?

This report on Prevention states that Pfizer and Moderna are testing a third "booster" dose for their Covid-19 vaccines, to ensure protection against variants (mutant strains) of the coronavirus. The report also states that Moderna has announced that it has finished making a variant-specific vaccine to target B.1.351, and the company is ready to begin a Phase 1 clinical trial of the vaccine.

This report by the BBC says that Moderna's research shows that their vaccine appears to work against variants.

This report by the BBC states that the AstraZeneca vaccine "offers less South Africa variant protection". The company is developing a modified jab, slated to be ready by the autumn, to combat the South Africa variant.

How often will we need to get re-vaccinated?

As reported here by the Mail Online, the UK government's chief scientific adviser, Sir Patrick Vallance, has said that we will need re-vaccination on a yearly basis.

Side-effects of vaccines

There are understandable concerns about the side-effects of various vaccines:

  • This piece on Live Science reports on new data released by the US Centers for Disease Control and Prevention (CDC) which shows that strong allergic reactions to Moderna's COVID-19 vaccine are extremely rare;
  • There have been reports from Denmark that the AstraZeneca vaccine can cause blood clots, which has caused several countries to suspend or restrict the use of this vaccine (here, on the BBC, here, on the BBC, here, on the BBC, here, on the BBC, );

The World Health Organisation (WHO), however, says that the benefits of the AstraZeneca vaccine outweigh the risks, and should continue to be used, as reported here by the BBC.

Delays in Vaccination Roll-Out in Europe

As reported by the BBC continental Europe is suffering major problems in getting their populace vaccinated, only partly due to supply issues.

Germany, which prides itself on its organisational skills, is having a particularly hard time, due in part to their difficulties making their minds up about how to do things, as reported here by Politico. They offered self-test kits to all the schools and kindergartens, then backtracked. They also recently offered all kindergarten staff vaccinations, putting them ahead of many others in the queue, but what they offered was the AstraZeneca vaccine which it seems no-one wants. There seems to be no programme to pro-actively contact people when they can be given the vaccine; I am at higher than normal risk, being 65 years old and having type-2 diabetes and high blood pressure, but it seems that I need to take the initiative to register for immunisation.

Germany continues to be reactive, rather than proactive, as shown by the debacle over the AstraZeneca vaccine. Fist they limited it to under 65s, then approved it for all ages, then promoted it for kindergarten workers, then barred it for all.


A large number of herbal treatments have been tested for use against the coronavirus, as have many pre-existing and new drugs:

  • This report on News Medical describes a study by researchers in the United States showing that a compound found in cannabis plants inhibited infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human lung cells;
  • This report on The Times of Israel describes a study showing that aspirin may protect against COVID-19; people who take small doses of aspirin (75mg) are less likely to be infected, and recover more quickly;
  • This report on Fox13 describes a study which showed that an experimental COVID-19 pill called Molnupiravir, by Merck and Ridgeback Biotherapeutics, showed promising signs of effectiveness in reducing the virus in patients;
  • This report on The Daily Mail describes a study which showed that people taking statins (used to reduce cholesterol in the bloodstream) were 50% less likely to die from Covid-19;
  • This report on the BBC describes a new study showing that the arthritis drug tocilizumab cuts deaths from Covid-19;
  • A small clinical study in Italy and China has revealed that an anticancer drug, bevacizumab, could help mitigate mortality and boost recovery from the coronavirus, as reported here on The Hindu Business Line;
  • This report by BGR describes a phase 1 trial for a new drug called EXO-C24 that was found to cure COVID-19 in 3-5 days in most volunteers who received the drug;
  • This report by BGR describes a study of the cancer drug plitidepsin, showing that it is 30 times more potent against Covid-119 than remdesivir and can work against the highly infectious new mutations;
  • This report by DW (Deutsche Welle) explains that Germany has approved the use of the REGN-COV2 monoclonal antibody to treat Covid-19 patients;
  • This report on News Medical describes a study showing that St. John's Wort and Echinacea could protect against COVID-19.


Experts continue to recommend wearing masks, social distancing and frequent hand washing or disinfection as the best way to avoid infection. They also recommend working from home wherever possible, although for many this is not an option.

This piece on The Mirror also reports that people who wear glasses are up to three times less likely to catch Covid, according to a recent study.

Having Covid-19

It seems that men are at greater risk from Covid-19 (more likely to contract the virus, suffer from severe complications, and die from the disease) than women, according to a large study (reported on here by New Atlas).

Even more worrying is this report on the Daily Mail, which describes research by Leicester University and the Office for National Statistics (ONS) showing that a third of "recovered" Covid-19 patients are readmitted to hospital within five months and one-in-eight of the Covid patients then died.